WINDSOR, Conn., Jan. 9, 2025 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services and healthcare software and software-enabled services, will announce its financial results for the fourth quarter and full year ended December 31, 2024 after the close of the market on Thursday, February 6, 2025. The earnings conference call, scheduled for Thursday, February 6, 2025 at 5:00 p.m. Eastern Time, will discuss fourth quarter and full year 2024 results and 2025 guidance.
Details of the release are as follows:
News Release: To be released on February 6, 2025. The release will be available over PR Newswire and from SS&C’s website at www.ssctech.com. To receive the press release via email immediately after wire distribution, visit investor.ssctech.com and click on Email Alerts.
Earnings Call: Dial 888-210-4650 (US and Canada) or 646-960-0327 (International) and request the “SS&C Technologies Fourth Quarter and Full Year 2024 Earnings Conference Call”; conference ID #4673675.
Webcast: A live webcast of its earnings conference call will be available at the Investor Relations section of SS&C’s website, investor.ssctech.com. A replay will be available after the conclusion of the live webcast.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 20,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.
Follow SS&C on X, LinkedIn, and Facebook.
SOURCE SS&C
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…
Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal…